PortalPublikationenFailure of buspirone and verapamil to improve spasmodic tort...

Failure of buspirone and verapamil to improve spasmodic torticollis.

Standard

Failure of buspirone and verapamil to improve spasmodic torticollis. / Naber, Dieter; Weinberger, D R; Gillespie, M; Chase, T N.

in: J NEUROPSYCH CLIN N, Jahrgang 4, Nr. 1, 1, 1992, S. 82-84.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Naber, D, Weinberger, DR, Gillespie, M & Chase, TN 1992, 'Failure of buspirone and verapamil to improve spasmodic torticollis.', J NEUROPSYCH CLIN N, Jg. 4, Nr. 1, 1, S. 82-84. <http://www.ncbi.nlm.nih.gov/pubmed/1627968?dopt=Citation>

APA

Naber, D., Weinberger, D. R., Gillespie, M., & Chase, T. N. (1992). Failure of buspirone and verapamil to improve spasmodic torticollis. J NEUROPSYCH CLIN N, 4(1), 82-84. [1]. http://www.ncbi.nlm.nih.gov/pubmed/1627968?dopt=Citation

Vancouver

Naber D, Weinberger DR, Gillespie M, Chase TN. Failure of buspirone and verapamil to improve spasmodic torticollis. J NEUROPSYCH CLIN N. 1992;4(1):82-84. 1.

Bibtex

@article{4e422a61ce3649f9985b030ef0feafe4,
title = "Failure of buspirone and verapamil to improve spasmodic torticollis.",
abstract = "The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.",
author = "Dieter Naber and Weinberger, {D R} and M Gillespie and Chase, {T N}",
year = "1992",
language = "Deutsch",
volume = "4",
pages = "82--84",
journal = "J NEUROPSYCH CLIN N",
issn = "0895-0172",
publisher = "American Psychiatric Publishing Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Failure of buspirone and verapamil to improve spasmodic torticollis.

AU - Naber, Dieter

AU - Weinberger, D R

AU - Gillespie, M

AU - Chase, T N

PY - 1992

Y1 - 1992

N2 - The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.

AB - The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.

M3 - SCORING: Zeitschriftenaufsatz

VL - 4

SP - 82

EP - 84

JO - J NEUROPSYCH CLIN N

JF - J NEUROPSYCH CLIN N

SN - 0895-0172

IS - 1

M1 - 1

ER -